Orbiva and Articura Sign MOU for Healthcare AI in Indonesia
Orbiva, a wholly owned subsidiary of Home Control International, signed a strategic cooperation MOU with Indonesia based Articura on July 23, 2026, the companies announced in a press release. At the signing ceremony, Orbiva also introduced products tailored for the Articura project.
The companies plan to work on healthcare AI infrastructure and digital health solutions for Indonesia. The scope includes healthcare AI reasoning rule systems, healthcare data and knowledge systems for hospitals and clinics, home healthcare, remote monitoring, digital health records, and AI use in hospital settings.
Planned hospital functions include AI enabled consultation before visits, patient triage, clinical decision support, medical record quality control, patient follow up, and tools for hospital operations. Orbiva will contribute AI, AIoT smart device, healthcare data processing, and edge computing technology, while Articura will provide healthcare deployment experience, hospital system integration, and local hospital networks.
Articura also plans to establish a National AI Healthcare Lab for demonstrations, model validation, research, and professional education. Representatives from Indonesia's Ministry of Health and Ministry of Communication and Digital Affairs attended the signing ceremony.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
Orbis Wins AWS Award for AI Premature Infant Eye Screening
ACL Digital Launches AgentixCare for Healthcare Operations
Andor Health Receives 2026 Frost & Sullivan Recognition for AI Care Orchestration
Oura to Buy AI Care Company Counsel Health for $625 Million
Daily AI Brief: the AI news that matters, in your inbox.